Search
Maze Therapeutics Inc
MAZEAdd to Watchlist
25.680USD
+0.840+3.38%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.42BMarket Cap
LossP/E TTM
Maze Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Maze Therapeutics Inc is 6.70, ranking 301 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -10.90, which is -1980.51% below the recent high of 205.07 and -85.78% above the recent low of -20.26.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
